Escape from targeted inhibition: the dark side of kinase inhibitor therapy

Cell Cycle. 2010 May;9(9):1661-2. doi: 10.4161/cc.9.9.11592. Epub 2010 May 16.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Cycle Proteins / metabolism
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Humans
  • Neoplasms / drug therapy
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Antineoplastic Agents
  • Cell Cycle Proteins
  • Protein Kinase Inhibitors
  • ErbB Receptors